Actively Recruiting

Age: 18Years +
All Genders
NCT05632419

Prognosis of Patients Who Presented With a State of Extreme Agitation.

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-04-04

608

Participants Needed

1

Research Sites

208 weeks

Total Duration

On this page

Sponsors

A

Assistance Publique - Hôpitaux de Paris

Lead Sponsor

L

Lariboisière-Saint Louis clinical research unit

Collaborating Sponsor

AI-Summary

What this Trial Is About

The main objective is to assess the 6-month prognosis of patients who presented with extreme agitation in the emergency room. The primary endpoint is the 6-month mortality of agitated patients.

CONDITIONS

Official Title

Prognosis of Patients Who Presented With a State of Extreme Agitation.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Agitated patient with the presence of three major criteria, namely,
  • restlessness
  • insensitivity to pain
  • tachypnea (fr>20)

and the presence of a minor criterion among

  • sweating
  • skin hyperthermia
  • non-compliance with law enforcement
  • tirelessness
  • unusual strength
  • inappropriate clothing, nudity
Not Eligible

You will not qualify if you...

  • patient age < 18 years
  • head trauma
  • pregnancy
  • detained
  • other obvious causes of pain leading to restlessness (renal colic, migraines, etc.)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Avicenne Hospital - Aphp

Bobigny, Île-de-France Region, France, 93000

Actively Recruiting

Loading map...

Research Team

F

Frédéric Adnet, MD, PhD

CONTACT

E

Eric Vicaut, MD, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here